Literature DB >> 11071446

Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients.

F Gelbert1, O Enjolras, D Deffrenne, A Aymard, C Mounayer, J J Merland.   

Abstract

Labial venous malformations are relatively common. Depending on their size, they are responsible for functional and cosmetic handicap. When treatment is indicated, it will be based on percutaneous sclerotherapy, using Ethibloc or Aetoxysclerol, with surgery in some patients. Our purpose was to review 23 patients with soft-tissue venous malformations of the lips. Follow-up ranged from 6 months to 4 years. Sclerotherapy alone or with surgical resection achieved good results in 18 patients. In six patients mild improvement was obtained. No worsening of the initial clinical situation occurred, and no persistent complication was observed. We discuss the indications for treatment and the different types of sclerosing agent. Percutaneous sclerotherapy is safe and is effective for small and medium-size labial malformations. For larger lesions the treatment is more complex and combined long term sclerotherapy and surgery procedures may be required over several years.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071446     DOI: 10.1007/s002340000364

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  9 in total

1.  Embolization in the head and neck.

Authors:  Daniel Cooke; Basavaraj Ghodke; Sabareesh Kumar Natarajan; Danial Hallam
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

2.  Complications of embolization.

Authors:  José I Bilbao; Antonio Martínez-Cuesta; Femín Urtasun; Octavio Cosín
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

3.  Changing concept on vascular malformation: no longer enigma.

Authors:  Byung-Boong Bb Lee
Journal:  Ann Vasc Dis       Date:  2008-02-15

4.  Percutaneous ethanol sclerotherapy of venous malformations of the tongue.

Authors:  Philip L Johnson; Donald A Eckard; Marci A Brecheisen; Douglas A Girod; Terrence T Tsue
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

5.  A new sclerosing agent in the treatment of venous malformations. Study on 23 cases.

Authors:  K Sannier; A Dompmartin; J Théron; D Labbé; M T Barrellier; R Leroyer; P Touré; D Leroy
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

6.  Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations.

Authors:  Anne Dompmartin; Xavier Blaizot; Jacques Théron; Frank Hammer; Yannick Chene; Daniel Labbé; Marie-Thérèse Barrellier; Cathy Gaillard; Robert Leroyer; Valérie Chedru; Catherine Ollivier; Miikka Vikkula; Laurence M Boon
Journal:  Eur Radiol       Date:  2011-08-07       Impact factor: 5.315

7.  Oral capillary hemangioma: a clinical protocol of diagnosis and treatment in adults.

Authors:  Walessa Brasil da Silva; André Luis Ribeiro Ribeiro; Sílvio Augusto Fernandes de Menezes; João de Jesus Viana Pinheiro; Sérgio de Melo Alves-Junior
Journal:  Oral Maxillofac Surg       Date:  2013-11-22

Review 8.  [Hemangiomas and vascular malformations in the area of the head and neck].

Authors:  U Ernemann; J Hoffmann; E Grönewäller; H Breuninger; H Rebmann; C Adam; S Reinert
Journal:  Radiologe       Date:  2003-11       Impact factor: 0.635

9.  Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: an experimental study.

Authors:  Masahide Fujiki; Masakazu Kurita; Mine Ozaki; Hayato Kawakami; Nobuyuki Kaji; Akihiko Takushima; Kiyonori Harii
Journal:  J Plast Surg Hand Surg       Date:  2012-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.